36F79723D0219-75A50324F80013
Delivery Order
Overview
Government Description
XOFLUZA (BALOXAVIR MARBOXIL)
Awardee
Awarding / Funding Agency
Place of Performance
South San Francisco, CA 94080 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity
(Parent Award)
Analysis Notes
Subcontracting Plan This Delivery Order has a Commercial Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Genentech Usa was awarded
Delivery Order 75A50324F80013 (75A503-24-F-80013)
for Xofluza (BALOXAVIR MARBOXIL)
worth up to $21,999,907
by the HHS Office of the Assistant Secretary for Preparedness and Response
in September 2024.
The contract
has a duration of 1 year and
was awarded
through solicitation 75A50324Q00014
full & open
with
NAICS 325412 and
PSC 6505
via subject to multiple award fair opportunity acquisition procedures with 1 bid received.
Status
(Open)
Last Modified 9/27/24
Period of Performance
9/30/24
Start Date
9/29/25
Current End Date
9/29/25
Potential End Date
Obligations
$22.0M
Total Obligated
$22.0M
Current Award
$22.0M
Potential Award
Award Hierarchy
Activity Timeline
People
Suggested agency contacts for 36F79723D0219-75A50324F80013
Competition
Number of Bidders
1
Solicitation Procedures
Subject To Multiple Award Fair Opportunity
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Commercial Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
SA85BMHCTXK5
Awardee CAGE
53VP4
Agency Detail
Awarding Office
75A503 ASPR/ORM-SNS
Funding Office
75A503
Created By
hhsterrireed
Last Modified By
hhsterrireed
Approved By
hhsterrireed
Legislative
Legislative Mandates
None Applicable
Performance District
CA-15
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Representative
Kevin Mullin
Modified: 9/27/24